pCMV-PE2-tagRFP-BleoR
(Plasmid
#192508)
-
PurposeExpression of PE2 in mammalian cells with co-expression of tagRFP and Zeocin resistance gene.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 192508 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCMV-PE2 (#132775)
-
Backbone manufacturerDavid Liu
-
Vector typeMammalian Expression
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePE2-P2A-tagRFP-P2A-BleoR
-
Alt namePrime editor 2-P2A-tagRFP-P2A-BleoR
-
SpeciesSynthetic; SpCas9 is from Streptococcus pyogenes; MMLV_RT is from the Moloney murine leukemia virus
-
Insert Size (bp)7512
-
Tags
/ Fusion Proteins
- SV40 bpNLS (N terminal on insert)
- SV40 bpNLS (C terminal on insert)
- tagRFP (C terminal on insert)
- BleoR (C terminal on insert)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCMV-PE2-tagRFP-BleoR was a gift from Gerald Schwank (Addgene plasmid # 192508 ; http://n2t.net/addgene:192508 ; RRID:Addgene_192508) -
For your References section:
Predicting prime editing efficiency and product purity by deep learning. Mathis N, Allam A, Kissling L, Marquart KF, Schmidheini L, Solari C, Balazs Z, Krauthammer M, Schwank G. Nat Biotechnol. 2023 Jan 16. doi: 10.1038/s41587-022-01613-7. 10.1038/s41587-022-01613-7 PubMed 36646933